tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Upstream Bio Inc

UPB
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
2.780USD
-0.080-2.80%
์ข…๊ฐ€ย 11-13 16:00๏ผˆET๏ผ‰
152.26M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Upstream Bio Inc ์ •๋ณด ํšŒ์‚ฌ

Upstream Bio, Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist in clinical development, that targets the receptor for thymic stromal lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. It has advanced this highly potent monoclonal antibody into separate phase II trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and plans to initiate development in chronic obstructive pulmonary disease. TSLP is a member of a class of epithelial cytokines, also including IL-25 and IL-33, commonly referred to as alarmins. TSLP is primarily produced by epithelial cells, especially in the lung, gastrointestinal tract and skin.

Upstream Bio Inc ํ”„๋กœํ•„

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ UPB
ํšŒ์‚ฌ ์ด๋ฆ„Upstream Bio Inc
์ƒ์žฅ์ผOct 11, 2024
CEOSutherland (E. Rand)
์ง์› ์ˆ˜52
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒOct 11
์ฃผ์†Œ890 Winter Street, Suite 200
๋„์‹œWALTHAM
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ02451
์ „ํ™”17812082466
์›น์‚ฌ์ดํŠธhttps://upstreambio.com/
์ข…๋ชฉ ์ฝ”๋“œ UPB
์ƒ์žฅ์ผOct 11, 2024
CEOSutherland (E. Rand)

Upstream Bio Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Dr. Adam Houghton, Ph.D.
Dr. Adam Houghton, Ph.D.
Chief Business Officer
Chief Business Officer
22.90K
-3.06%
Ms. Allison Ambrose, J.D.
Ms. Allison Ambrose, J.D.
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
15.56K
-3.12%
Mr. Ronald C. (Ron) Renaud, Jr.
Mr. Ronald C. (Ron) Renaud, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Aaron Deykin, M.D.
Dr. Aaron Deykin, M.D.
Chief Medical Officer, Head - Research and Development
Chief Medical Officer, Head - Research and Development
--
-100.00%
Dr. E. Rand Sutherland, M.D.
Dr. E. Rand Sutherland, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Michael Paul (Mike) Gray
Mr. Michael Paul (Mike) Gray
Chief Financial and Operating Officer
Chief Financial and Operating Officer
--
--
Ms. Daniella Beckman
Ms. Daniella Beckman
Independent Director
Independent Director
--
--
Mr. Erez Chimovits
Mr. Erez Chimovits
Independent Director
Independent Director
--
--
Dr. H. Edward Fleming, Jr., M.D.
Dr. H. Edward Fleming, Jr., M.D.
Independent Director
Independent Director
--
--
Mr. Dayton C. Misfeldt
Mr. Dayton C. Misfeldt
Independent Director
Independent Director
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Dr. Adam Houghton, Ph.D.
Dr. Adam Houghton, Ph.D.
Chief Business Officer
Chief Business Officer
22.90K
-3.06%
Ms. Allison Ambrose, J.D.
Ms. Allison Ambrose, J.D.
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
15.56K
-3.12%
Mr. Ronald C. (Ron) Renaud, Jr.
Mr. Ronald C. (Ron) Renaud, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Aaron Deykin, M.D.
Dr. Aaron Deykin, M.D.
Chief Medical Officer, Head - Research and Development
Chief Medical Officer, Head - Research and Development
--
-100.00%
Dr. E. Rand Sutherland, M.D.
Dr. E. Rand Sutherland, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Michael Paul (Mike) Gray
Mr. Michael Paul (Mike) Gray
Chief Financial and Operating Officer
Chief Financial and Operating Officer
--
--

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Upstream Bio Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
Upstream Bio Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค: Dr. Adam Houghton, Ph.D.

Upstream Bio Inc(UPB)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2026Q1 ๊ธฐ์ค€์œผ๋กœ, Upstream Bio Inc์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 235๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 56.28M๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 103.41%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q4 ๋Œ€๋น„ 2571675.00 ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ